In a significant health breakthrough, India's first-ever registry of childhood cancer survivors has shown impressive results. The study reveals a 94.5% overall survival rate after five years and nearly 90% of survivors are free from complications. This study was part of the Indian Childhood Cancer Survivorship (C2S) study, launched in 2016, and was published in The Lancet Regional Health Southeast Asia journal.

What Happened?

The C2S study is a groundbreaking initiative. It gathers data on children who were diagnosed with cancer before turning 18 and who have now achieved remission after treatment. Researchers from notable institutions like the All India Institute of Medical Sciences (AIIMS) and Rajiv Gandhi Cancer Institute and Research Centre in New Delhi collaborated on this important research. They followed 5,419 children diagnosed with cancer across 20 centers in India.

Of these participants, survival data was available for 5,140 children. The study found that acute leukaemia was the most common form of cancer among survivors, accounting for 40.9% of cases. The results show that the overall five-year survival rate for this group was 94.5%, while nearly 90% experienced event-free survival. This means most of the survivors do not have complications from their treatment.

Key Highlights

The C2S study is India's first registry of childhood cancer survivors.
It reported a 94.5% overall survival rate for survivors after five years.
Nearly 90% of survivors remain free of complications.
Acute leukaemia was the most common diagnosis, affecting 40.9% of participants.
About 94.7% of participants underwent chemotherapy as a treatment method.
Survival rates for participants followed for at least two years reached 98.2% overall.
The study can help inform policy and future research on childhood cancer survivorship in India.

Why Does This Matter?

This news is important for several reasons. First, it shows that significant progress has been made in treating childhood cancer in India. High survival rates bring hope to families dealing with such difficult diagnoses. Knowing that most children do survive cancer and can live healthy lives is vital for parents and caregivers.

Moreover, the study highlights that despite many challenges in healthcare, collaboration between public and private institutions in different areas of India can lead to positive outcomes. The success of this registry allows for better understanding and improvement of treatment for childhood cancer survivors.

What Are People Saying?

What Happens Next?

Frequently Asked Questions (FAQ)

Q: What is the C2S study? A: The C2S study is India's first registry tracking children who survive cancer, launched in 2016.
Q: How many children were part of the study? A: The study involved 5,419 children diagnosed with cancer before age 18.
Q: What was the survival rate found in the study? A: The study found a 94.5% overall survival rate for survivors after five years.

Conclusion

The findings of India's first childhood cancer survivor registry bring hope for better treatment and outcomes. With high survival rates and ongoing research, there is a promising future for childhood cancer survivors in India.